214 related articles for article (PubMed ID: 24694602)
1. Potential use of niosomal hydrogel as an ocular delivery system for atenolol.
Abu Hashim II; El-Dahan MS; Yusif RM; Abd-Elgawad AE; Arima H
Biol Pharm Bull; 2014; 37(4):541-51. PubMed ID: 24694602
[TBL] [Abstract][Full Text] [Related]
2. Formulation and investigation of pilocarpine hydrochloride niosomal gels for the treatment of glaucoma: intraocular pressure measurement in white albino rabbits.
Jain N; Verma A; Jain N
Drug Deliv; 2020 Dec; 27(1):888-899. PubMed ID: 32551978
[TBL] [Abstract][Full Text] [Related]
3. Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide.
Guinedi AS; Mortada ND; Mansour S; Hathout RM
Int J Pharm; 2005 Dec; 306(1-2):71-82. PubMed ID: 16263229
[TBL] [Abstract][Full Text] [Related]
4. Enhanced ocular bioavailability of fluconazole from niosomal gels and microemulsions: formulation, optimization, and in vitro-in vivo evaluation.
Soliman OAE; Mohamed EA; Khatera NAA
Pharm Dev Technol; 2019 Jan; 24(1):48-62. PubMed ID: 29210317
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of 8-methoxypsoralen topical delivery via nanosized niosomal vesicles: Formulation development, in vitro and in vivo evaluation of skin deposition.
Kassem AA; Abd El-Alim SH; Asfour MH
Int J Pharm; 2017 Jan; 517(1-2):256-268. PubMed ID: 27956194
[TBL] [Abstract][Full Text] [Related]
6. Formulation and in vitro assessment of minoxidil niosomes for enhanced skin delivery.
Balakrishnan P; Shanmugam S; Lee WS; Lee WM; Kim JO; Oh DH; Kim DD; Kim JS; Yoo BK; Choi HG; Woo JS; Yong CS
Int J Pharm; 2009 Jul; 377(1-2):1-8. PubMed ID: 19394413
[TBL] [Abstract][Full Text] [Related]
7. Influence of a niosomal formulation on the oral bioavailability of acyclovir in rabbits.
Attia IA; El-Gizawy SA; Fouda MA; Donia AM
AAPS PharmSciTech; 2007 Dec; 8(4):E106. PubMed ID: 18181527
[TBL] [Abstract][Full Text] [Related]
8. Development of brimonidine niosomes laden contact lenses for extended release and promising delivery system in glaucoma treatment.
Tripathi S; Yadav KS
Daru; 2024 Jun; 32(1):161-175. PubMed ID: 38158475
[TBL] [Abstract][Full Text] [Related]
9. Latanoprost niosomes as a sustained release ocular delivery system for the management of glaucoma.
Fathalla D; Fouad EA; Soliman GM
Drug Dev Ind Pharm; 2020 May; 46(5):806-813. PubMed ID: 32281424
[No Abstract] [Full Text] [Related]
10. Development of a topical niosomal preparation of acetazolamide: preparation and evaluation.
Aggarwal D; Garg A; Kaur IP
J Pharm Pharmacol; 2004 Dec; 56(12):1509-17. PubMed ID: 15563757
[TBL] [Abstract][Full Text] [Related]
11. Preparation and characterization of niosomes containing ribavirin for liver targeting.
Hashim F; El-Ridy M; Nasr M; Abdallah Y
Drug Deliv; 2010 Jul; 17(5):282-7. PubMed ID: 20350052
[TBL] [Abstract][Full Text] [Related]
12. Effect of formulation compositions on niosomal preparations.
Chaw CS; Kim KY
Pharm Dev Technol; 2013; 18(3):667-72. PubMed ID: 22468904
[TBL] [Abstract][Full Text] [Related]
13. Niosome-encapsulated gentamicin for ophthalmic controlled delivery.
Abdelbary G; El-Gendy N
AAPS PharmSciTech; 2008; 9(3):740-7. PubMed ID: 18563578
[TBL] [Abstract][Full Text] [Related]
14. Formulation of Niosomal Gel for Enhanced Transdermal Lornoxicam Delivery: In-Vitro and In-Vivo Evaluation.
El-Ridy MS; Yehia SA; Mohsen AM; El-Awdan SA; Darwish AB
Curr Drug Deliv; 2018; 15(1):122-133. PubMed ID: 28240177
[TBL] [Abstract][Full Text] [Related]
15. Design and in vitro characterization of small unilamellar niosomes as ophthalmic carrier of dorzolamide hydrochloride.
Hasan AA
Pharm Dev Technol; 2014 Sep; 19(6):748-54. PubMed ID: 23964893
[TBL] [Abstract][Full Text] [Related]
16. Sublingual fast dissolving niosomal films for enhanced bioavailability and prolonged effect of metoprolol tartrate.
Allam A; Fetih G
Drug Des Devel Ther; 2016; 10():2421-33. PubMed ID: 27536063
[TBL] [Abstract][Full Text] [Related]
17. Sorbitan ester niosomes for topical delivery of rofecoxib.
Das MK; Palei NN
Indian J Exp Biol; 2011 Jun; 49(6):438-45. PubMed ID: 21702223
[TBL] [Abstract][Full Text] [Related]
18. Preparation and evaluation of optimized zolmitriptan niosomal emulgel.
Mohamed MI; Abdelbary AA; Kandil SM; Mahmoud TM
Drug Dev Ind Pharm; 2019 Jul; 45(7):1157-1167. PubMed ID: 30919700
[No Abstract] [Full Text] [Related]
19. Formulation and Evaluation of Niosomal in situ Nasal Gel of a Serotonin Receptor Agonist, Buspirone Hydrochloride for the Brain Delivery via Intranasal Route.
Mathure D; Madan JR; Gujar KN; Tupsamundre A; Ranpise HA; Dua K
Pharm Nanotechnol; 2018; 6(1):69-78. PubMed ID: 29380709
[TBL] [Abstract][Full Text] [Related]
20. Design and in vitro evaluation of doxycycline hyclate niosomes as a potential ocular delivery system.
Gugleva V; Titeva S; Rangelov S; Momekova D
Int J Pharm; 2019 Aug; 567():118431. PubMed ID: 31207279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
